Corbus Pharmaceuticals (NASDAQ:CRBP) Given New $56.00 Price Target at Oppenheimer
Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) had its target price reduced by Oppenheimer from $60.00 to $56.00 in a research report released on Wednesday,Benzinga reports. Oppenheimer currently has an outperform rating on the biopharmaceutical company’s stock. CRBP has been the topic of several other reports. Jefferies Financial Group lowered their price target on shares of […]
More Stories
Dynamic Advisor Solutions LLC Purchases New Holdings in Vanguard Emerging Markets Government Bond ETF (NASDAQ:VWOB)
Dynamic Advisor Solutions LLC purchased a new stake in Vanguard Emerging Markets Government Bond ETF (NASDAQ:VWOB – Free Report) in...
Dynamic Advisor Solutions LLC Invests $1.77 Million in The Bank of New York Mellon Co. (NYSE:BK)
Dynamic Advisor Solutions LLC acquired a new position in The Bank of New York Mellon Co. (NYSE:BK – Free Report)...
SPDR S&P Dividend ETF (NYSEARCA:SDY) Shares Sold by Dynamic Advisor Solutions LLC
Dynamic Advisor Solutions LLC reduced its stake in shares of SPDR S&P Dividend ETF (NYSEARCA:SDY – Free Report) by 9.2%...
Opal Wealth Advisors LLC Buys New Holdings in Seacoast Banking Co. of Florida (NASDAQ:SBCF)
Opal Wealth Advisors LLC purchased a new stake in shares of Seacoast Banking Co. of Florida (NASDAQ:SBCF – Free Report)...
Dynamic Advisor Solutions LLC Has $2.09 Million Stock Holdings in Primo Brands Co. (NYSE:PRMB)
Dynamic Advisor Solutions LLC cut its stake in Primo Brands Co. (NYSE:PRMB – Free Report) by 3.9% during the first...
Fidelity MSCI Utilities Index ETF (NYSEARCA:FUTY) Shares Sold by Dynamic Advisor Solutions LLC
Dynamic Advisor Solutions LLC lessened its holdings in shares of Fidelity MSCI Utilities Index ETF (NYSEARCA:FUTY – Free Report) by...